Hepatopancreaticobiliary cancers affect the liver, pancreas, gallbladder and bile ducts. These organs are closely connected anatomically, yet cancers arising from them can behave differently and require highly individualised treatment strategies.
Understanding the evaluation process is especially important because symptoms may initially resemble common digestive or liver-related conditions.
Which Cancers Fall Into This Group?
Hepatopancreaticobiliary, often shortened to HPB, cancers commonly include:
- Primary liver cancer
- Pancreatic cancer
- Gallbladder cancer
- Intrahepatic bile duct cancer
- Extrahepatic bile duct cancer
Tumours affecting the ampulla and nearby structures may also require specialised HPB evaluation.
The exact location of a tumour can significantly influence whether surgery is possible and what type of operation may be required.
Symptoms Can Be Subtle
HPB cancers do not always cause obvious symptoms during their early stages.
Depending on the affected organ, a person may experience:
- Upper abdominal discomfort
- Unexplained weight loss
- Reduced appetite
- Persistent nausea
- Jaundice
- Dark urine
- Pale stools
- Itching
- Unexplained fatigue
Jaundice occurs when bilirubin accumulates in the body and may cause yellowing of the eyes and skin. Although jaundice can result from several non-cancerous conditions, it requires medical assessment.
How Doctors Investigate Suspected HPB Cancer
Evaluation usually begins with medical history, examination and blood investigations.
Imaging plays a particularly important role.
Ultrasound may identify abnormalities in the liver, gallbladder or bile ducts. CT and MRI scans can provide more detailed information about the tumour and surrounding structures.
Certain situations may require MRCP, endoscopic ultrasound or other specialised investigations.
A biopsy may be necessary in some cases, although whether tissue sampling is performed before surgery depends on the suspected cancer and proposed treatment strategy.
Determining Whether a Tumour Is Operable
One of the most important questions after diagnosis is whether the tumour can be removed surgically.
This is more complex than simply measuring tumour size.
Surgeons evaluate factors such as:
- Relationship with major blood vessels
- Involvement of nearby organs
- Presence of distant disease
- Liver function
- Overall health
- Expected remaining liver volume when liver surgery is planned
High-quality imaging therefore becomes essential before major HPB surgery is considered.
Different Cancers Require Different Operations
There is no single operation called HPB cancer surgery.
For liver tumours, surgery may involve removing a segment or larger portion of the liver.
Pancreatic tumours may require different procedures depending on whether the cancer lies in the head, body or tail of the pancreas.
Gallbladder cancer surgery can vary according to how deeply the disease has extended beyond the gallbladder.
Bile duct operations depend heavily on the precise anatomical location of the tumour.
Surgery May Be Only One Part of Treatment
Cancer care often combines surgery with systemic treatment.
Chemotherapy may be recommended before surgery for selected patients or after an operation based on pathology findings and disease characteristics.
Some patients have tumours that cannot initially be removed safely. In such circumstances, other treatments may be considered before surgical options are reassessed.
This makes multidisciplinary review particularly valuable.
Questions Patients Can Ask
Before deciding on treatment, patients and families may find it useful to ask:
- Where exactly is the tumour located?
- Has it spread outside the original organ?
- Is surgery currently possible?
- What operation is being considered?
- Will chemotherapy be needed?
- What are the expected risks?
- How will recovery affect nutrition and daily activity?
Patients in Mumbai often receive reports from different diagnostic centres and hospitals. Bringing previous scans, pathology reports, discharge summaries and treatment records to a consultation can help avoid unnecessary duplication.
Dr. Sasmita Vadgaonkar provides surgical oncology assessment in Vile Parle for patients requiring evaluation of hepatopancreaticobiliary cancers.
Because HPB cancers differ significantly in their anatomy and treatment, careful imaging review, staging and multidisciplinary planning are essential before major treatment decisions are made.
